Medrx converts 6.13% of new warrant issue into shares in June
The Tokyo Growth-listed company delivered 906,000 new shares in the first month of a June 5 warrant issue, while rights linked to 13,876,000 shares remained unexercised at month-end.
Revenue¥128m−50.3% year on yearConsolidated · FY12/25
Ordinary profit−¥937mConsolidated · FY12/25
Net profit−¥937mConsolidated · FY12/25
Employees, whole group21 peopleFY12/25
Employees, parent company (non-consolidated)20 peopleFY12/25
Average salary¥6.16mFY12/25
Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.
| Fiscal year | Revenue | Ordinary profit | Net profit (attributable) | EPS | Total assets | Net assets | Op. cash flow |
|---|---|---|---|---|---|---|---|
| FY12/25 | ¥128.08m−50.3% year on year | −¥937m | −¥937m | −¥17.44 | ¥2.16bn | ¥2.05bn | −¥888m |
| FY12/24 | ¥257.92m+773.3% year on year | −¥755m | −¥807m | −¥18.56 | ¥2.28bn | ¥2.17bn | −¥803m |
| FY12/23 | ¥29.53m−50.3% year on year | −¥931m | −¥933m | −¥26.82 | ¥2.05bn | ¥1.92bn | −¥914m |
| FY12/22 | ¥59.48m+612.4% year on year | −¥1,112m | −¥1,111m | −¥43.81 | ¥1.40bn | ¥1.21bn | −¥1,073m |
| FY12/21 | ¥8.35m | −¥1,066m | −¥1,060m | −¥49.62 | ¥2.11bn | ¥1.96bn | −¥924m |
Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.
Figures from annual report S100XS7V · Japan GAAP. Each figure's years come from one report's five-year summary.
TSE:4586
The Tokyo Growth-listed company delivered 906,000 new shares in the first month of a June 5 warrant issue, while rights linked to 13,876,000 shares remained unexercised at month-end.
All articles loaded · 1 shown
Latest disclosed holders and exits below 5%.
No stored data for this selection.
| Holder | Stake | Change | Purpose | Filing |
|---|---|---|---|---|
Growth Capital Inc.Original (Japanese)グロース・キャピタル株式会社 | 4.35% | −1.06 pp | Pure investmentPure investmentOriginal (Japanese)純投資 | Filed — filing S100ZHKZ |